Reading Time: 4 minutes

In a groundbreaking advancement for neurodegenerative disease treatment, researchers at UT Southwestern Medical Center have revealed promising results from their phase two clinical trials involving gold nanoparticles. This innovative therapy, utilizing gold nanocrystals suspended in a water buffer, has shown significant potential in reversing brain deficits associated with multiple sclerosis (MS) and Parkinson’s disease (PD). The findings, published in the Journal of Nanobiotechnology, offer new hope for patients suffering from these debilitating conditions.

The Challenge of Neurodegenerative Diseases

Neurodegenerative diseases such as MS, PD, and amyotrophic lateral sclerosis (ALS) are characterized by the progressive loss of neuron function and structure, leading to severe disabilities. A critical aspect of these diseases is the decline in brain energy metabolism, marked by a decrease in the ratio of nicotinamide adenine dinucleotide (NAD+) to its reduced form, NADH. This ratio is vital for the production of adenosine triphosphate (ATP), the primary energy carrier in cells. In neurodegenerative conditions, this decline is not only faster but also more severe, exacerbating the neurological deficits.

Gold Nanoparticles: A Revolutionary Solution

Gold nanoparticles represent a novel therapeutic approach to address these challenges. These tiny particles act as catalysts to improve the NAD+/NADH ratio, thereby enhancing the energy metabolism of brain cells. Previous studies in cellular and animal models have demonstrated that gold nanoparticles can significantly boost brain energy balance, providing a solid foundation for clinical trials in human subjects.

Clinical Trial Success

The phase two clinical trials, known as REPAIR-MS and REPAIR-PD, involved 24 participants—11 with relapsing MS and 13 with Parkinson’s. The trials aimed to evaluate the efficacy of gold nanoparticles in improving brain energy metabolism and functional outcomes. Participants took a daily dose of the gold nanocrystal suspension for 12 weeks, during which they underwent brain magnetic resonance (MR) spectroscopy scans to measure their NAD+/NADH ratios and other metabolic markers.

The Results Were Impressive:

Ratio Improvement

On average, participants experienced a 10.4% increase in their NAD+/NADH ratios compared to baseline levels, indicating a significant improvement in brain energy metabolism.

of ATP Levels:

By the end of the treatment period, ATP levels normalized to the group mean, suggesting that gold nanoparticles positively affected overall brain energy metabolism.

Improvements in PD Patients:

Using a validated survey, researchers observed that PD patients reported improved motor experiences of daily living, highlighting potential functional benefits of gold nanoparticles.

Notably, none of the participants experienced severe adverse side effects, underscoring the safety profile of this innovative therapy.

Implications and Future Directions

Dr. Peter Sguigna, Assistant Professor of Neurology at UT Southwestern and lead investigator of the MS trial, expressed cautious optimism about these findings. He emphasized that the ability to halt or even reverse neurological disabilities could revolutionize the treatment landscape for neurodegenerative diseases. However, he also highlighted the need for further studies to validate these results in larger patient populations and different stages of these diseases.

The continuation of the REPAIR-MS trial aims to determine whether similar benefits can be observed in progressive forms of MS, potentially broadening the therapeutic application of gold nanoparticles.

Promoting Colloidal Gold for Health

If you’re intrigued by the potential benefits of colloidal gold and want to explore its applications for enhancing brain function and overall health, consider incorporating high-quality colloidal gold into your wellness routine. Visit Gold Healing to discover their premium colloidal gold products. Known for its purity and efficacy, colloidal gold from Gold Healing is crafted to support cognitive function, reduce inflammation, and promote overall well-being.


The development and clinical success of gold nanoparticles represent a significant leap forward in the treatment of neurodegenerative diseases. By improving brain energy metabolism, these tiny gold particles offer a novel and promising approach to managing diseases that currently have limited treatment options. As research progresses, gold nanoparticles could become a cornerstone therapy for neurodegenerative conditions, providing new hope and improved quality of life for millions of patients worldwide.

For more detailed information, you can refer to the study published in the Journal of Nanobiotechnology and other related scientific literature on the benefits of gold nanoparticles in neurodegenerative disease treatment.